Telesair, Inc. is at the forefront of transforming respiratory care through its innovative Bonhawa® High Flow Oxygen Therapy (HFOT) System. This device is designed to address the clinical needs of patients with respiratory insufficiency by providing high-quality, cost-effective oxygen therapy. The Bonhawa system features a unique combination of high flow rates, precise oxygen concentration, and humidity control, ensuring optimal patient comfort and compliance. It is capable of delivering oxygen at flow rates ranging from 2-25 LPM for pediatric patients and 10-80 LPM for adults, with adjustable temperature settings of 31ºC, 34ºC, and 37ºC. The system also includes real-time monitoring of oxygen levels and flow rates, which alerts clinicians to any interruptions in therapy, thereby enhancing patient safety.

In addition to its advanced therapeutic capabilities, the Bonhawa device is designed for ease of use and maintenance. It features a forward-facing touchscreen for easy visibility and quick adjustments, while its minimal and smart design allows for rapid cleaning and turnaround between patients. The device is lightweight and portable, equipped with battery solutions that provide over 90 minutes of functionality, making it suitable for both hospital and home environments. Telesair's commitment to innovation is further reflected in the Bonhawa's serviceable and upgradeable nature, ensuring that it remains a reliable tool for healthcare providers in delivering effective respiratory care.

United States

Telesair, Inc. is a Southern California based medical device company in stealth mode, that is developing breakthrough respiratory care solutions to help move patients from hospital to home sooner. Designed by respiratory veterans in both R&D and commercialization, our solutions elevate the existing standard of care by improving outcomes for patients and the health system.

Telesair, Inc

Company Details